Compounds for the treatment of hepatitis C
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Bristol-Myers Squibb Company
A C A
A61P C07D A61P
inventional inventional inventional
Samuel Zhongxing Tao Weixu Li-Qiang Guo Annapurna Zhiwei Paul Michael Eric
Gerritz Zhang Wang Zhai Sun Li Pendri Yin Scola Mull